Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...

Italian farmer Antonio Onorati, a member of the ECVC seeds working group, also raised concerns about the burden placed on farmers. Under the new rules, farmers could be required to prove they have not ...

The patent, titled “Combinations of IRS/STAT3 dual modulators and anti-cancer agents for treating cancer” addresses NT219 in combination with cetuximab (Erbitux) as well as other ...

Agilent Technologies Inc. and Synthego Corp. sparred Friday over whether Agilent patents related to a key component of the ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term momentum without new products.

Purdue University researchers have received $124,984 from the Trask Innovation Fund to develop Purdue-owned intellectual ...

The sequence contained a promising new genetic tool for modifying DNA, a CRISPR. Editas Medicine, a Massachusetts-based ...

As a pioneering gene editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas12a and CRISPR/Cas9 genome ... exclusive licensee of Broad Institute’s Cas12a ...

Where some saw an imperfect compromise, other attendees apparently left the talks in disgust. In published reports, for ...

CRISPR gene editing technology has shown to be a very versatile ... MN reports personal fees from Kiadis Pharma; in addition, MN has patents US62/825,007; WO2019222503A1; USPTO63/105,722; ...